# Intravenous Ondansetron to Attenuate the Hypotensive, Bradycardic Response to Spinal Anesthesia in Healthy Parturients

> **NCT01414777** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Virginia** · enrollment: 68 (actual)

## Conditions studied

- Hypotension
- Pregnancy

## Interventions

- **DRUG:** ondansetron
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01414777
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2022-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01414777

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01414777, "Intravenous Ondansetron to Attenuate the Hypotensive, Bradycardic Response to Spinal Anesthesia in Healthy Parturients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01414777. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*